Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSX:
$TGOD.TO) (TSX: $WBR.TO) (CSE: $TTT.C) (CSE: $AGRO.C) (CSE: $TER.C)
Delta, Kelowna, BC –August
14, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news
source covering leading sectors including marijuana and hemp stocks and its
potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/08141TGOD-WBR-TTT-AGRO-TER.asp
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts.
In
today’s podcast we look at a few early announcements.
The Green Organic Dutchman Holdings Ltd. (TSX:
TGOD) (OTC:
TGODF) reported its
financial and operational results for the three and six months ended June 30,
2019. These filings are available for review on the Company's SEDAR profile at
www.sedar.com.
Q2 Highlights:
The Company:
●
Is nearing completion of construction at
its Hamilton site and Phase 1 at its Valleyfield site, with investment
amounting to $53.1 million in the second quarter of 2019, bringing the total
additions year to date to $100.9 million.
●
Achieved revenues of $2.9 million, a 20%
increase over the prior quarter derived primarily from Europe. In Canada, the
Company launched its pilot "Grower's Circle", which included sales to
a small number of medical patients to test the market and the Company's
distribution capabilities. The Company launched two new products in Q2 and
expects to start a similar pilot in the Ontario recreational market during
Q3-2019.
●
Experienced a net loss of $16.6 million
for Q2-2019. Management continued to maintain a disciplined approach to
operational costs as it prepares for commercialization of its products in
Canada and internationally.
Other key updates in the quarter
The Company:
●
Announced provincial board supply
agreements with Alberta Cannabis and BC Cannabis Stores, expanding its
footprint in Western Canada.
●
Achieved its organic certification for
the Valleyfield facility from Pro-Cert, an internationally recognized organic
certification organization.
●
Signed a distribution agreement with
Mediakos UG haftunsbeschraenkt to be the exclusive distributor of CannibiGold,
HemPoland's premium hemp CBD brand, for the German pharmacy market. In
addition, the Company launched its Global Strategic Hemp Division.
●
Entered into a multi-year agreement with
Neptune Wellness Solutions Inc. for extraction, formulation and packaging
services. As part of the agreement, the Company will have exclusivity on
extraction, formulation and packaging of certified organic products within and
for the Canadian market.
"Q2 was pivotal for the Company as
we began commercial production in the second phase of our Hamilton site and
expanded our product line for the Grower's Circle," commented Brian
Athaide, CEO of TGOD. "The product quality feedback from the Grower's
Circle has been overwhelmingly positive, confirming that patients appreciate
having access to premium certified organic cannabis, an underserved segment of
the market. With double digit quarterly
growth in Europe and construction nearing completion in Canada, the team
continues to deliver on our ambitious business plan with executional
excellence. We now have our first
purchase order from the OCS in hand and look forward to shipping our first
recreational sales this week," continued Athaide.
Waterloo Brewing Ltd. (TSX:
WBR), Ontario's largest Canadian-owned
brewery,
today announced receipt of its research license for
cannabis-infused beverages. The Company is on track to be ready to commercially
produce such products for 2020.
"The cannabis market has garnered a
great deal of investor interest and after an in-depth review of our strategic
options, the Company is positioning itself to be a major producer of CIB's and
to take full advantage of this new and developing beverage category,"
stated George Croft, President and CEO, Waterloo Brewing. "We plan to be
the production partner of choice for the beverage cannabis business."
"Cannabis-infused beverages is an
unprecedented growth opportunity with an estimated market value of $1.5
billion," concluded Croft "and we are now in a highly advantaged
position to deliver significant value for our investors."
"We believe that due to technical
infrastructure issues related to the licensing and commercial production of
cannabis-infused beverages, we will be one of the few beverage production
facilities capable of producing these products," said Russell Tabata,
Chief Operating Officer. "We have
the equipment, the scale, the technical know-how and the speed to be able to
pull this off in this extremely tight timeframe," added Mr. Tabata.
Shoppers Drug Mart
today announced the successful completion of Phase 1 of
its blockchain-secured pilot program with software partner TruTrace Technologies Inc. (CSE:
TTT) (OTCQB:
TTTSF). The Pilot Program is specifically
designed to increase transparency, interoperability and product identification
within the medical cannabis industry. Shoppers has now engaged TruTrace and
Deloitte Canada LLP to execute Phase 2
of the Pilot Program, with full production and implementation of TruTrace's
StrainSecure platform targeted for late November 2019.
Phase 2 of the Pilot Program, using Deloitte's
project management and advisory capacity and TruTrace's StrainSecure™ system,
will be focused on developing a unified approach to medical cannabis standards,
onboarding licenced producers and other partners to track and trace all product
history—from genome to distribution. The
program is expected to help researchers and clinicians to match therapeutic
outcomes to specific genetic and chemical profiles, and provide physicians,
pharmacists, and patients with greater confidence in the products they prescribe
or consume.
Under their StrainSecure™ system, the
TruTrace team collects plant testing data and performs genomic verification in
plant batches which are then registered in a blockchain-enabled database for
intellectual property protection and strain validation. All information
gathered from the plants, including their molecular and chemical makeup, can be
tracked via the technology.
"We have been encouraged by the
response to this traceability initiative. There is a clear consensus within the
cannabis industry that the source and quality of medical cannabis must be
transparent and identifiable in order to meet the expectations of patients and
health care practitioners," said Ken Weisbrod, Vice President of Business
Development, Shoppers Drug Mart. "It is more important than ever to be
able to assure all stakeholders, from regulators to health care practitioners,
that the medical cannabis industry is taking the necessary steps to establish
the infrastructure required to deliver standardized, consistent medication to
our patients. Shoppers has turned to two
trusted leaders, TruTrace and Deloitte Canada LLP, to assist us in the second
phase of the project."
"As the cannabis sector continues to
rapidly evolve in Canada, the industry needs to increase transparency to all
stakeholders by demonstrating adherence to rigorous procedures to maintain the
overall integrity of the supply chain," said David Stewart, Partner within
Deloitte's Forensics practice. "Strengthening traceability and
verification of cannabis products will bring benefits to the industry as a
whole, and most importantly, build confidence and accountability into the cannabis
medical value chain. We are proud to be part of such an important initiative
given Deloitte Canada's leadership in the cannabis space."
Agrios
Global Holdings Ltd. (CSE:
AGRO) (OTCQB:
AGGHF) provided
an update on its data driven aeroponics platform.
Arable soil scarcity, climate change and
higher recurrence of extreme weather events are prompting a shift from outdoor
to indoor farming which has eco sustainable methods and less environmental
impact. According to GBC, an independent research firm, Agrios, a developer of
disruptive technology in the field of agri-tech, is "entering a growth
phase" as the global need for agri-tech innovations to support
eco-sustainable agronomy increases.
Agrios' data-driven aeroponic technology
can be used for any type of indoor cultivation. The Company's aeroponic
cultivation facilities are equipped with high precision sensors collecting
actionable data on 32 key cultivation metrics. Real time data is sent to Agrios'
proprietary software, where data analytics allow for precision cultivation,
enabling control of numerous variables, including but not limited to,
temperature, humidity, lighting, air quality, water, and nutrients.
Agrios' state-of-the-art aeroponic technologies
are an attractive solution for the cannabis cultivation industry as cannabis
requires specific conditions to grow well and cultivators must ensure these
conditions are optimized. Aeroponics greatly reduces the uncertainty of the
growing process and makes the duplication of results from one growth cycle to
the next one possible.
A major factor in the production of
cannabis is the cost of production and achieving consistent product quality.
The table below provides an overview of the costs of several cultivation
methods. While the cost to produce is lower in an outdoor grow facility,
producers are limited to cultivating between one to two crops annually, where
Agrios' aeroponic cultivation clients can harvest an average of five times per
annum.
Comparatively, growers that use Agrios'
indoor aeroponic platform can produce premium quality flower for approximately
$1.00 per gram, with higher yields of between 2.5 and 4.0 kilograms per m²
annually, nearly five times that of greenhouse yields and ten times that of
outdoor yields.
"Agrios' data-driven aeroponics
platform is highly advantageous to cannabis cultivators, as it substantially
lowers operating costs in the areas of energy, labor, nutrient and water
consumption, enabling our clients to remain competitive in today's cannabis
market." said Chris Kennedy, President & CEO of Agrios Global
Holdings.
TerrAscend Corp. (CSE:
TER) (OTCQX:
TRSSF)
today announced that it has completed its first international
shipment of dry cannabis flower to its German distribution partner iuvo
Therapeutics GmbH. The shipment was made
from TerrAscend's EU GMP certified manufacturing facility in Mississauga,
Ontario, Canada. As the Company ships additional product to Germany in
partnership with iuvo, it will continue to expand its footprint in Europe and
other international markets. The Company looks forward to providing investors
with updates on such expansion activities.
TerrAscend and iuvo, respectively were
granted an Export Permit by Health Canada, under the Cannabis Act, and an
Import Authorization from Germany's Federal Institute for Drugs and Medical
Devices, following the issuance of the Company's EU Good Manufacturing Practice
("GMP") certificate on April 29, 2019. TerrAscend is one of only six
companies with a GMP certified cannabis facility.
It is expected that the German cannabis
market will generate more than $5 billion in revenue by 2025. With more than
30,000 current medical cannabis patients in Germany and upwards of 7,200 kg in
annual medical patient consumption, the TerrAscend-iuvo partnership presents an
exciting opportunity to fulfill the growing needs of medical cannabis patients
in Germany.
"We look forward to bringing
TerrAscend's quality products to the German market and working with a partner
who is also focused on patient well-being," said Robyn Rabinovich, VP,
Cannabis Strategy and Partnerships, "This first shipment solidifies our
partnership with iuvo and will allow for ongoing access to high quality medical
cannabis products for German patients."
"We are pleased to commence our
first shipment to Germany together with our partner TerrAscend." Said
Daniel Seidi, Director and Co-Founder of iuvo "In close collaboration we
have successfully established a fully EU GMP/GDP licenced supply-chain of our
pharmaceuticals. This places us in a unique position to respond to the
supply-deficiency within the EU in the interest of the patients in need."
THORNTON
GROUT FINNIGAN LLP AND ROCHON GENOVA LLP have together commenced a class action
in Ontario on behalf of shareholders of CannTrust
Holdings Inc. (TSX:
TRST) (NYSE:
CTST) who acquired their CannTrust common
shares between October 1, 2018 up to and including July 8, 2019. The class
action seeks damages from CannTrust, certain of its officers and directors, and
its auditors KPMG, arising out of alleged misrepresentations in CannTrust's
required public disclosure, including its 2018 audited annual financial
statements.
Joel
P. Rochon, Managing Partner at Rochon Genova, said: "Accurate and timely
public disclosure is the lifeblood of our capital markets. Investors are
entitled to full, true and plain disclosure about Ontario reporting issuers.
Proper disclosure levels the playing field among all investors and enables them
to make informed decisions."
John
L. Finnigan, Founding Partner at Thornton Grout Finnigan, said: "The
integrity of our capital markets depends upon timely and accurate corporate
disclosure. Gatekeepers, such as auditors, play a critical role in protecting
investors; and this is particularly so when dealing with a nascent industry like
cannabis."
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
